Refine by
Inflammation Leading Technology
5 companies found
Technologybased inWildau, GERMANY
Behind BIOMES is a team of passionate and experienced scientists. We built our company on the basis of years of research work with the goal of making cutting-edge technologies accessible to everyone. Our vision: We want to help people live healthier ...
INTEST.pro is the first complete at home intestinal flora test with customised nutritional recommendations based on the analysis of bacterial DNA. Learn about your weak points and, thanks to cutting-edge scientific findings, find out what your ...
Technologybased inGaithersburg, MASSACHUSETTS (USA)
In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...
The current standard of care for autoimmune diseases is broad immunosuppression, which is associated with side effects and leaves patients vulnerable to serious infection and maligancies. Our approach to autoimmune disease is designed to ...
Technologybased inSalt Lake City,, UTAH (USA)
Alucent Biomedical is a privately held biomedical company focused on our vision to transform the way vascular disease is treated. We are focused on using advanced technology to harness the body’s own natural physiologic processes and structures. ...
PAD is a common circulatory problem in which narrowed arteries reduce blood flow to the extremities – generally affecting one or both legs. It is caused when the inner lining of arteries located outside of the heart get damaged by factors such ...
Technologybased inLabège, FRANCE
Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...
Bacterial translocation: the missing link between intestinal microbiome and human complex non-communicable diseases. Complex disorders are multifactorial and often chronic, caused by genetic and environmental factors and comprising hundreds of ...
Technologybased inWoburn, MASSACHUSETTS (USA)
Aegle Therapeutics is a first in class, phase 1/2a stage biotechnology company isolating extracellular vesicles including exosomes (EVs) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ...
Epidermolysis bullosa (“EB”) is a group of rare genetic disorders that manifests as blistering or erosion of the skin in response to little or no apparent trauma. There are many genetic and symptomatic variations of EB. EB is always ...